3CZ-11689-50300 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-30
Dose 1 — Pfizer-BioNTech
2021-10-31
Registered in v-safe
2021-11-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Nausea

Adult check-in
2021-11-02
Survey response — days 1–6 daily, dose 1
MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches

Free text: Sore throat runny nose mild

MedDRA releases: 2024-11 · check-in free text available
2021-11-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-11-06
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-11-20
Dose 2 — Pfizer-BioNTech
2021-11-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-30	Pfizer-BioNTech	No
2	2021-11-20	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 1

2021-11-02

Systemic reaction (other): Sore throat runny nose mild

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Oropharyngeal pain	·	·	✓
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release